Genetic screening alters diagnosis and management in patients with immune thrombocytopenia

Key Points

• To evaluate the impact of genetic screening on the diagnosis and management of immune thrombocytopenia.
• Analysis of genetic screening outcomes in patients with immune thrombocytopenia.
• Assessment of diagnostic changes post-screening.
• Evaluation of management strategies adjusted based on genetic findings.
• Genetic screening led to a revised diagnosis in a significant proportion of patients.
• Altered treatment strategies based on genetic findings resulted in improved patient outcomes.
• Identification of specific genetic markers enhanced personalized management plans.